These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 28748641)

  • 1. EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergy.
    Sturm GJ; Varga EM; Roberts G; Mosbech H; Bilò MB; Akdis CA; Antolín-Amérigo D; Cichocka-Jarosz E; Gawlik R; Jakob T; Kosnik M; Lange J; Mingomataj E; Mitsias DI; Ollert M; Oude Elberink JNG; Pfaar O; Pitsios C; Pravettoni V; Ruëff F; Sin BA; Agache I; Angier E; Arasi S; Calderón MA; Fernandez-Rivas M; Halken S; Jutel M; Lau S; Pajno GB; van Ree R; Ryan D; Spranger O; van Wijk RG; Dhami S; Zaman H; Sheikh A; Muraro A
    Allergy; 2018 Apr; 73(4):744-764. PubMed ID: 28748641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venom immunotherapy for preventing allergic reactions to insect stings.
    Boyle RJ; Elremeli M; Hockenhull J; Cherry MG; Bulsara MK; Daniels M; Oude Elberink JN
    Cochrane Database Syst Rev; 2012 Oct; 10(10):CD008838. PubMed ID: 23076950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
    von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
    Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH; Farhoudi A; Pourpak Z; Gharagozlou M; Movahedi M; Nabavi M; Mozafari H; Mohammadzadeh I; Chavoshzadeh Z; Shirkhoda Z
    Iran J Allergy Asthma Immunol; 2007 Dec; 6(4):203-6. PubMed ID: 18094443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.
    Hockenhull J; Elremeli M; Cherry MG; Mahon J; Lai M; Darroch J; Oyee J; Boland A; Dickson R; Dundar Y; Boyle R
    Health Technol Assess; 2012; 16(12):III-IV, 1-110. PubMed ID: 22409877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis.
    Dhami S; Zaman H; Varga EM; Sturm GJ; Muraro A; Akdis CA; Antolín-Amérigo D; Bilò MB; Bokanovic D; Calderon MA; Cichocka-Jarosz E; Oude Elberink JN; Gawlik R; Jakob T; Kosnik M; Lange J; Mingomataj E; Mitsias DI; Mosbech H; Ollert M; Pfaar O; Pitsios C; Pravettoni V; Roberts G; Ruëff F; Sin BA; Asaria M; Netuveli G; Sheikh A
    Allergy; 2017 Mar; 72(3):342-365. PubMed ID: 28120424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with Hymenoptera venoms. Position paper of the Working Group on Immunotherapy of the European Academy of Allergy and Clinical Immunology.
    Bousquet J; Müller UR; Dreborg S; Jarisch R; Malling HJ; Mosbech H; Urbanek R; Youlten L
    Allergy; 1987 Aug; 42(6):401-13. PubMed ID: 3310714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis.
    Roberts G; Pfaar O; Akdis CA; Ansotegui IJ; Durham SR; Gerth van Wijk R; Halken S; Larenas-Linnemann D; Pawankar R; Pitsios C; Sheikh A; Worm M; Arasi S; Calderon MA; Cingi C; Dhami S; Fauquert JL; Hamelmann E; Hellings P; Jacobsen L; Knol EF; Lin SY; Maggina P; Mösges R; Oude Elberink JNG; Pajno GB; Pastorello EA; Penagos M; Rotiroti G; Schmidt-Weber CB; Timmermans F; Tsilochristou O; Varga EM; Wilkinson JN; Williams A; Zhang L; Agache I; Angier E; Fernandez-Rivas M; Jutel M; Lau S; van Ree R; Ryan D; Sturm GJ; Muraro A
    Allergy; 2018 Apr; 73(4):765-798. PubMed ID: 28940458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hymenoptera venom allergy.
    Przybilla B; Ruëff F
    J Dtsch Dermatol Ges; 2010 Feb; 8(2):114-27; quiz 128-30. PubMed ID: 19751222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of venom immunotherapy on serum level of CCL5/RANTES in patients with Hymenoptera venom allergy.
    Gawlik R; Glück J; Jawor B; Rogala B
    Immunopharmacol Immunotoxicol; 2015; 37(4):375-9. PubMed ID: 26181651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New developments in the diagnosis and treatment of hymenoptera venom allergy.
    Müller UR
    Int Arch Allergy Immunol; 2001 Apr; 124(4):447-53. PubMed ID: 11340327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview.
    Asaria M; Dhami S; van Ree R; Gerth van Wijk R; Muraro A; Roberts G; Sheikh A
    Allergy; 2018 Feb; 73(2):269-283. PubMed ID: 28718981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated basal serum tryptase and hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy.
    Haeberli G; Brönnimann M; Hunziker T; Müller U
    Clin Exp Allergy; 2003 Sep; 33(9):1216-20. PubMed ID: 12956741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity.
    Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Seitz MJ; Aberer W; Bodzenta-Lukaszyk A; Bonifazi F; Campi P; Darsow U; Haeberli G; Hawranek T; Küchenhoff H; Lang R; Quercia O; Reider N; Schmid-Grendelmeier P; Severino M; Sturm GJ; Treudler R; Wüthrich B
    PLoS One; 2013; 8(5):e63233. PubMed ID: 23700415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Follow-Up of Children after Venom Immunotherapy: Low Adherence to Anaphylaxis Guidelines.
    Fiedler C; Miehe U; Treudler R; Kiess W; Prenzel F
    Int Arch Allergy Immunol; 2017; 172(3):167-172. PubMed ID: 28380475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusive Bee Venom Allergy: Risk Factors and Outcome of Immunotherapy.
    Rosman Y; Nashef F; Cohen-Engler A; Meir-Shafrir K; Lachover-Roth I; Confino-Cohen R
    Int Arch Allergy Immunol; 2019; 180(2):128-134. PubMed ID: 31216540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
    Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
    Roll A; Hofbauer G; Ballmer-Weber BK; Schmid-Grendelmeier P
    J Investig Allergol Clin Immunol; 2006; 16(2):79-85. PubMed ID: 16689180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuing venom immunotherapy.
    Golden DB
    Curr Opin Allergy Clin Immunol; 2001 Aug; 1(4):353-6. PubMed ID: 11964712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity.
    Ruëff F; Przybilla B; Biló MB; Müller U; Scheipl F; Aberer W; Birnbaum J; Bodzenta-Lukaszyk A; Bonifazi F; Bucher C; Campi P; Darsow U; Egger C; Haeberli G; Hawranek T; Körner M; Kucharewicz I; Küchenhoff H; Lang R; Quercia O; Reider N; Severino M; Sticherling M; Sturm GJ; Wüthrich B
    J Allergy Clin Immunol; 2009 Nov; 124(5):1047-54. PubMed ID: 19895993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.